Clinical Trials Browser

Phase 1/2 × Carcinoma, Renal Cell × temsirolimus × Clear all

NCT00112840 2022-02-01

CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer

Phase 1/2 Completed

60 enrolled 11 charts

Carcinoma, Renal Cell

NCT02423954 2018-07-02

NivoPlus

Phase 1/2 Terminated

GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Pancreatic Neoplasms, Colorectal Neoplasms